U
Acura Pharmaceuticals, Inc. ACUR
$0.0055 $0.002266.67%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2021 06/30/2021 03/31/2021 12/31/2020 09/30/2020
Revenue -34.15% -54.63% -40.97% -41.15% -69.03%
Total Other Revenue -- -- -- -- --
Total Revenue -34.15% -54.63% -40.97% -41.15% -69.03%
Cost of Revenue -25.82% -12.36% 4.65% -7.53% 11.61%
Gross Profit -5.50% -75.39% -66.05% -61.85% -112.69%
SG&A Expenses -8.77% 7.84% -25.82% -13.79% -16.79%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -17.85% -1.83% -12.80% -10.73% -3.75%
Operating Income 6.02% -171.26% -178.92% -148.70% -281.67%
Income Before Tax 61.36% -225.65% 56.47% -256.77% -439.00%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 61.36% -225.65% 56.47% -256.77% -439.00%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 61.36% -225.65% 56.47% -256.77% -439.00%
EBIT 6.02% -171.26% -178.92% -148.70% -281.67%
EBITDA 6.06% -163.95% -151.00% -133.33% -243.42%
EPS Basic 83.33% -194.74% 56.52% -253.06% -433.33%
Normalized Basic EPS 66.41% -193.33% -457.14% -251.61% -427.50%
EPS Diluted 83.33% -205.26% 50.00% -304.08% -433.33%
Normalized Diluted EPS 66.41% -194.92% -457.14% -251.61% -427.50%
Average Basic Shares Outstanding 133.67% 32.77% 0.60% 1.93% 2.35%
Average Diluted Shares Outstanding 133.67% 32.04% 0.60% 1.93% 2.35%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings